Nurturing a supportive 
payer environment

Sustainable access to innovation in rare diseases and oncology hinges on having the right policy and payer frameworks.

Meaningful impact requires thought leadership – we believe that industry needs to proactively shape the policy debate, not only react to it.

At Prescient, we help our clients identify the access policy imperatives most important to their portfolios. We generate compelling evidence, develop credible payer proposals, and engage with stakeholders to drive positive change or flexibility within existing decision-making frameworks.